The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

It is easy to assume that the prostate is healthy when there is no usual discomfort during urination. However, prostate ...

CLEVELAND, Ohio — A genomic test used to assess prostate cancer risk may also help doctors determine which patients are ...

San Francisco 49ers tight end George Kittle has teamed up with Novartis to raise awareness of prostate cancer and highlight ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

A systematic review of sixteen studies finds that emerging serum and urine protein biomarkers, including PHI, PSP94/PSA ratio ...

Asymptomatic prostate-specific antigen (PSA) testing in primary care was associated with a lower risk for mortality due to prostate cancer than no testing. Researchers conducted a nested case-control ...

A new test can identify men who are more at risk of dying from prostate cancer and allow for more personalised treatment.

The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...

A simple blood test to detect cancer before symptoms even appear: that’s the promise of liquid biopsy, a rapidly developing ...

An optimized SNEDDS formulation of flutamide achieved rapid self-emulsification, near-complete drug release, and stronger ...

(AP) -- Men finally may be getting a clearer message about undergoing PSA screening for prostate cancer: Don't do it. They may not listen. After all, the vast majority of men over 50 already get ...